Schedule 13G ownership disclosure

Caribou Biosciences Inc

Common Stock · CUSIP: 142038108

Event date: 2024-12-31

Filing-level shares
1,951,065.00
Percent of class
2.2%
  • BANK OF AMERICA CORP /DE/

    Shares: 1,951,065.00 · Class: 2.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000070858-25-000122
Form type
SCHEDULE 13G/A
Filer
BANK OF AMERICA CORP /DE/
CIK
CIK 70858
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub